Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000222,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67475,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000213,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67476,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000316,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67477,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000358,serum insulin level,,,,0.000339,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67478,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000358,serum insulin level,,,,0.000301,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66176,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000358,serum insulin level,,,,0.000408,mg/dl,0.0,2.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66177,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,87,mg/dl,1.2,5.6285,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13206,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,105.6,mg/dl,1.5,7.0356,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13207,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,112,mg/dl,2.2,10.3189,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13208,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,106,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13209,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,107.3,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13210,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,88.8,mg/dl,1.4,5.6,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13211,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,127,mg/dl,3.2,12.8,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13212,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,127.1,mg/dl,3.5,14.0,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13213,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,126.8,mg/dl,2.7,10.8,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13214,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000046,blood glucose level,,,,124.8,mg/dl,2.6,10.4,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13215,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,85.9,mg/dl,1.8,6.9714,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13216,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,114.6,mg/dl,3.2,12.3935,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13217,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,116.4,mg/dl,2.9,11.2317,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13218,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,114.8,mg/dl,3.0,11.619,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13219,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,111.9,mg/dl,2.5,9.6825,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13220,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,89.5,mg/dl,1.1,4.7948,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13221,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,120.7,mg/dl,2.5,10.8972,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13222,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,125.4,mg/dl,3.2,13.9485,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13223,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,118.8,mg/dl,2.4,10.4614,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13224,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000046,blood glucose level,,,,119.3,mg/dl,3.1,13.5126,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13225,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,89.8,mg/dl,2.2,7.9322,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13226,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,118.5,mg/dl,3.5,12.6194,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13227,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,119.5,mg/dl,2.1,7.5717,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13228,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,119.8,mg/dl,3.4,12.2589,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13229,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,122.6,mg/dl,3.1,11.1772,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13230,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,89.5,mg/dl,2.2,8.5206,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13231,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,108.2,mg/dl,2.9,11.2317,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13232,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,110.4,mg/dl,2.8,10.8444,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13233,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,107.4,mg/dl,2.3,8.9079,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13234,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000046,blood glucose level,,,,105.9,mg/dl,2.0,7.746,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13235,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,80,mg/dl,2.9,10.0459,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13236,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,111.8,mg/dl,2.6,9.0067,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13237,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,113,mg/dl,2.6,9.0067,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13238,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,111.6,mg/dl,2.1,7.2746,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13239,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000046,blood glucose level,,,,111.5,mg/dl,2.1,7.2746,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13240,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,90,mg/dl,4.2,13.2816,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13241,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,118.4,mg/dl,4.0,12.6491,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13242,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,115.3,mg/dl,2.2,6.957,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13243,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,115.2,mg/dl,2.7,8.5381,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13244,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,115.2,mg/dl,3.4,10.7517,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13245,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,81.3,mg/dl,2.0,5.6569,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13246,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,100.1,mg/dl,2.4,6.7882,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13247,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,99.6,mg/dl,3.2,9.051,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13248,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,101.1,mg/dl,3.4,9.6167,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13249,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000046,blood glucose level,,,,103.5,mg/dl,3.0,8.4853,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13250,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,84.4,mg/dl,1.5,5.4083,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13251,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,100,mg/dl,2.3,8.2928,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13252,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,103,mg/dl,2.6,9.3744,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13253,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,102.2,mg/dl,1.8,6.49,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13254,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000046,blood glucose level,,,,103.5,mg/dl,2.3,8.2928,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13255,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,91.4,mg/dl,1.1,4.1158,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13256,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,114.8,mg/dl,1.9,7.1091,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13257,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,118.3,mg/dl,1.7,6.3608,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13258,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,119,mg/dl,2.0,7.4833,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13259,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000046,blood glucose level,,,,118.9,mg/dl,2.2,8.2316,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13260,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,89,mg/dl,2.4,7.5895,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13261,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,105.9,mg/dl,2.6,8.2219,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13262,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,105.8,mg/dl,2.8,8.8544,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13263,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,102.2,mg/dl,2.4,7.5895,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13264,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000046,blood glucose level,,,,102,mg/dl,2.6,8.2219,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13265,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,84.7,mg/dl,1.9,5.0269,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13266,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,100.9,mg/dl,3.0,7.9373,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13267,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,105.6,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13268,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,96.7,mg/dl,1.2,3.1749,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13269,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000046,blood glucose level,,,,103.7,mg/dl,1.2,3.1749,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13270,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000046,blood glucose level,,,,78,mg/dl,2.6,6.879,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12770,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000046,blood glucose level,,,,78.7,mg/dl,3.4,8.9956,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12786,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000046,blood glucose level,,,,82.5,mg/dl,3.5,11.6082,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12792,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000046,blood glucose level,,,,87.7,mg/dl,3.2,10.6132,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12798,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000118,GK/KyoSwe,not specified,65 days,22,,CMO:0000046,blood glucose level,,,,140.4,mg/dl,5.4,25.3282,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11384,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000118,GK/KyoSwe,not specified,65 days,22,,CMO:0000046,blood glucose level,,,,352.8,mg/dl,14.4,67.542,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,30,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11385,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000118,GK/KyoSwe,not specified,65 days,22,,CMO:0000046,blood glucose level,,,,363.6,mg/dl,12.6,59.0992,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,60,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11386,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000118,GK/KyoSwe,not specified,65 days,22,,CMO:0000046,blood glucose level,,,,298.8,mg/dl,12.6,59.0992,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11387,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000179,F344/DuCrl,not specified,65 days,10,,CMO:0000046,blood glucose level,,,,147.6,mg/dl,10.8,34.1526,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,30,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11394,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000179,F344/DuCrl,not specified,65 days,10,,CMO:0000046,blood glucose level,,,,93.6,mg/dl,7.2,22.7684,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,60,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11395,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000179,F344/DuCrl,not specified,65 days,10,,CMO:0000046,blood glucose level,,,,64.8,mg/dl,3.6,11.3842,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11396,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000179,F344/DuCrl,not specified,65 days,10,,CMO:0000046,blood glucose level,,,,55.8,mg/dl,5.4,17.0763,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11393,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood insulin amount,,RS:0000118,GK/KyoSwe,not specified,65 days,4,,CMO:0000349,blood insulin level,,,,12.5,mU/l,6.7,13.4,MMO:0000075,enzyme linked immunosorbent assay,,,,glucose injection,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11389,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood insulin amount,,RS:0000179,F344/DuCrl,not specified,65 days,3,,CMO:0000349,blood insulin level,,,,23.6,mU/l,4.9,8.487,MMO:0000075,enzyme linked immunosorbent assay,,,,glucose injection,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11398,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood insulin amount,,RS:0000118,GK/KyoSwe,not specified,65 days,4,,CMO:0000354,change in blood insulin level,,change from baseline,,4,mU/l,2.9,5.8,MMO:0000075,enzyme linked immunosorbent assay,,,,glucose injection,30,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11390,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood insulin amount,,RS:0000118,GK/KyoSwe,not specified,65 days,4,,CMO:0000354,change in blood insulin level,,change from baseline,,8.8,mU/l,4.4,8.8,MMO:0000075,enzyme linked immunosorbent assay,,,,glucose injection,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11391,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood insulin amount,,RS:0000179,F344/DuCrl,not specified,65 days,3,,CMO:0000354,change in blood insulin level,,,,-3.2,mU/l,6.1,10.5655,MMO:0000075,enzyme linked immunosorbent assay,,,,glucose injection,30,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11399,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood insulin amount,,RS:0000179,F344/DuCrl,not specified,65 days,3,,CMO:0000354,change in blood insulin level,,,,2.4,mU/l,8.0,13.8564,MMO:0000075,enzyme linked immunosorbent assay,,0,,glucose injection,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11400,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000625,OLETF/Got,male,245 days,14,,CMO:0000042,plasma glucose level,,converted from mg/dl,,102.2,mg/dl,2.7528,10.3,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,0,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11402,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",
83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000625,OLETF/Got,male,245 days,14,,CMO:0000042,plasma glucose level,,converted from mg/dl,,301.3,mg/dl,8.2316,30.8,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,30,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11403,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",
83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,245 days,15,,CMO:0000042,plasma glucose level,,converted from mg/dl,,92.6,mg/dl,1.6525,6.4,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,30,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11405,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",
83,Ogino Genom 2000 Nov 15;70(1):19-25.,blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,245 days,15,,CMO:0000042,plasma glucose level,,converted from mg/dl,,80,mg/dl,1.2394,4.8,MMO:0000113,oral glucose tolerance test,tail vein,0,,gastric gavage,0,min,"fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) ",11404,fasting (for 12 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,153,mg/dl,3.4,10.7517,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13196,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,332.1,mg/dl,8.0,25.2982,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13197,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,337.9,mg/dl,7.9,24.982,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13198,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,423.5,mg/dl,23.6,74.6298,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13199,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000042,plasma glucose level,,,,289.7,mg/dl,8.2,25.9307,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13200,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,104,mg/dl,6.1,16.1391,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13201,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,124.1,mg/dl,1.6,4.2332,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13202,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,130.9,mg/dl,2.9,7.6727,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13203,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,139,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13204,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000042,plasma glucose level,,,,128,mg/dl,2.4,6.3498,MMO:0000113,oral glucose tolerance test,tail,,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",glucose challenge by gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13205,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000042,plasma glucose level,,,,80,mg/dl,3.1,9.3,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66172,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000042,plasma glucose level,,,,88.1,mg/dl,1.8,8.0498,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66173,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000118,GK/KyoSwe,not specified,65 days,22,,CMO:0000350,blood glucose level area under curve (AUC),,,,38399.999616,(mg/dl) x min,1163.6364,5457.9383,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,,,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11388,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
82,"Galli J, et al., NatGenet 1996 Jan;12(1):31-7.",blood glucose amount,,RS:0000179,F344/DuCrl,not specified,65 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,11563.636248,(mg/dl) x min,418.1818,1322.407,MMO:0000164,intraperitoneal glucose tolerance test,tail vein,,"Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany)",glucose injection,,,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",11397,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000012,body weight,,,,423.2,g,7.3,24.2114,MMO:0000016,body weighing method,,0.0,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12803,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000012,body weight,,,,393.6,g,6.2,16.4037,MMO:0000016,body weighing method,,,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12785,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000012,body weight,,,,368.7,g,8.7,23.018,MMO:0000016,body weighing method,,,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12791,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000012,body weight,,,,425.3,g,5.3,17.5781,MMO:0000016,body weighing method,,0.0,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12797,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000305,F344/DuCrlCrlj,male,210 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,15300,(mg/dl) x min,206.7,546.8768,MMO:0000113,oral glucose tolerance test,tail,0.0,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67194,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
228,"Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58",blood glucose amount,,RS:0000625,OLETF/Got,male,210 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,39445.5,(mg/dl) x min,1058.0,3345.6898,MMO:0000113,oral glucose tolerance test,tail,0.0,"Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan)",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67195,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000350,blood glucose level area under curve (AUC),,,,12619.8,(mg/dl) x min,142.8,669.7914,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67778,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,210 days,16,,CMO:0000350,blood glucose level area under curve (AUC),,,,14626.9,(mg/dl) x min,209.1,836.4,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67779,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001958,F344.OLETF-(D14Rat8-D14Rat26)/2Tj,male,210 days,15,,CMO:0000350,blood glucose level area under curve (AUC),,,,13342,(mg/dl) x min,278.7,1079.4005,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67780,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001738,F344.OLETF-(D8Rat54-D8Mgh17)/2Tj,male,210 days,19,,CMO:0000350,blood glucose level area under curve (AUC),,,,14077.1,(mg/dl) x min,223.3,973.3421,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67781,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001937,F344.OLETF-(D11Mgh4-D11Mgh1)/2Tj,male,210 days,13,,CMO:0000350,blood glucose level area under curve (AUC),,,,13921.2,(mg/dl) x min,193.4,697.3136,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67782,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001964,F344.OLETF-(D1Mit20-D1Mgh26)/2Tj,male,210 days,15,,CMO:0000350,blood glucose level area under curve (AUC),,,,12711.3,(mg/dl) x min,281.0,1088.3083,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67783,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000292,F344.OLETF-(D1Rat166-D1Rat90)/Tj,male,210 days,12,,CMO:0000350,blood glucose level area under curve (AUC),,,,13082.5,(mg/dl) x min,171.3,593.4006,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67784,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001969,F344.OLETF-(D5Mgh4-D5Rat21)/Tj,male,210 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,13545,(mg/dl) x min,178.8,565.4152,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67785,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001987,F344.OLETF-(D9Mgh8-D9Mit2)/2Tj,male,210 days,8,,CMO:0000350,blood glucose level area under curve (AUC),,,,11797.5,(mg/dl) x min,291.2,823.638,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67786,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0001940,F344.OLETF-(D12Wox5-D12Rat21)/Tj,male,210 days,13,,CMO:0000350,blood glucose level area under curve (AUC),,,,11972.3,(mg/dl) x min,199.4,718.9469,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67787,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000290,F344.OLETF-(D14Rat8-D14Rat26)/Tj,male,210 days,14,,CMO:0000350,blood glucose level area under curve (AUC),,,,13716.4,(mg/dl) x min,166.7,623.7343,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67788,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000291,F344.OLETF-(D16Wox4-D16Rat13)/Tj,male,210 days,10,,CMO:0000350,blood glucose level area under curve (AUC),,,,12282,(mg/dl) x min,221.8,701.3932,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67789,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000286,F344.OLETF-(D10Wox7-D10Wox6)/Tj,male,210 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,11920.7,(mg/dl) x min,192.1,508.2488,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67790,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ",
716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000350,blood glucose level area under curve (AUC),,,,12200,(mg/dl) x min,174.0,522.0,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66174,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,210 days,20,,CMO:0000350,blood glucose level area under curve (AUC),,,,14600,(mg/dl) x min,354.0,1583.1361,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66175,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ",
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000780,serum leptin level,,,,5.46,ng/ml,1.06,2.8045,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67483,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,211 days,7,,CMO:0000780,serum leptin level,,,,2.8,ng/ml,0.54,1.4287,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67484,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000780,serum leptin level,,,,6.28,ng/ml,0.51,1.6915,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67485,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "
311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,211 days,11,,CMO:0000780,serum leptin level,,,,5.82,ng/ml,0.59,1.9568,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67486,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) "